Transplantation of D15A-Expressing Glial-Restricted-Precursor-Derived Astrocytes Improves Anatomical and Locomotor Recovery after Spinal Cord Injury

Int. J. Biol. Sci., 2013 · DOI: 10.7150/ijbs.5626 · Published: December 22, 2012

Spinal Cord Injury Regenerative Medicine Neurology

Simple Explanation

This study explores a cell-based therapy for spinal cord injury (SCI) using glial-restricted precursor (GRP) cells, which are early-stage cells that can develop into glial cells like astrocytes. The researchers modified GRPs to become astrocytes (GDAs) and express a neurotrophic factor called D15A, which supports nerve cell growth and survival. They transplanted these modified GDAs into rats with spinal cord injuries and observed improvements in anatomical structure and locomotor function, suggesting a potential therapeutic approach for SCI.

Study Duration

8 weeks

Participants

Adult Fischer 344 rats

Evidence Level

Not specified

Key Findings

1
Transplantation of D15A-GDAs significantly increased the spared white matter and decreased the injury size compared to control groups.
2
Transplantation of D15A-GDAs significantly improved the locomotion function recovery shown by BBB locomotion scores and Tredscan footprint analyses.
3
Transplantation of GRPs, GDAs or D15A-GDAs did not cause allodynia.

Research Summary

The study investigates the therapeutic potential of transplanting glial-restricted precursor-derived astrocytes (GDAs) expressing the neurotrophin D15A into rats with spinal cord injuries (SCI). The results demonstrate that D15A-GDAs transplantation promotes anatomical recovery by increasing spared white matter and reducing injury size, as well as improving locomotor function. The findings suggest that combining GDA transplantation with neurotrophin expression could be an effective therapeutic strategy for SCI without exacerbating neuropathic pain.

Practical Implications

Therapeutic Potential for SCI

The use of D15A-expressing GDAs could be a promising therapeutic approach for spinal cord injury.

Neuroprotection Mechanism

Functional recovery after D15A-GDA transplantation may come from mechanisms other than remyelination; neuroprotection is suggested as one of the important mechanisms.

Combination Therapy

Combining GDA transplantation with neurotrophin expression may yield better outcomes than GDA transplantation alone.

Study Limitations

1
The study used a contusion injury model, which may not fully represent all types of SCI, and the microenvironment in different injury models may induce different behavior in grafted GDAs.
2
The precise mechanisms underlying the functional recovery after D15A-GDA transplantation, particularly regarding axonal regeneration and sprouting, require further investigation due to the complexity of the incomplete contusion injury model.
3
It is difficult to study its effects on axonal regeneration and sprouting in the incomplete contusion injury since the spared and regenerated axons are not easy to distinguish in this injury model.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury